Figure 11.2.1

Figure 11.2.1

Kaplan-Meier analysis of survival for 431 intermediate-risk neuroblastoma patients enrolled on the Pediatric Oncology Group Neuroblastoma Biology Study 9047 between 1990 and 1999. (Survival curve provided by W. London,COG Statistics and Data Center. Risk groups were determined by INSS stage, age, MYCN status, tumor cell ploidy, and available histology.)

Table 11.2.1 The Children's Oncology Group Intermediate-risk Protocol A3961.Treatment is stratified by biology subgrouping

INSS stage

Age (days)


Favorable biology

0 0

Post a comment